Evaxion A (EVAX) Net Income (2020 - 2026)
Evaxion A (EVAX) posted Net Income of -$4.1 million for Q1 2026, up 36.83% on a QoQ basis from -$6.4 million in Q4 2025, and down 106.77% year-over-year from $60.0 million in Q1 2025.
Evaxion A (EVAX) Net Income (2020 - 2026) Analysis & Trends
Evaxion A's Net Income history runs 7 years deep, the most recent figure standing at -$4.1 million for Q1 2026.
- Quarterly Net Income fell 106.77% year-over-year to -$4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.6 million (up 21.81% YoY) and the FY2025 annual result came in at -$9.5 million, up 21.58% from the prior year.
- Net Income was -$4.1 million for Q1 2026 at Evaxion A, up from -$6.4 million in the prior quarter.
- Across five years, Net Income topped out at $5.8 million in Q1 2022 and bottomed at -$7.2 million in Q4 2022.
- A 5-year average of -$2.7 million and a median of -$4.2 million in 2024 frame the typical range for Net Income.
- Annual changes were most pronounced in 2024 — Net Income tumbled 2818.58% — and 2025, when it surged 292.15%.
- Evaxion A's Net Income stood at -$7.2 million in 2022, then surged by 32.43% to -$4.9 million in 2023, then increased by 14.31% to -$4.2 million in 2024, then sank by 53.84% to -$6.4 million in 2025, then jumped by 36.83% to -$4.1 million in 2026.
- Business Quant data shows EVAX's Net Income at -$4.1 million in Q1 2026, -$6.4 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | -4.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.06 Mn |
| Dec 31, 2025 | -6.43 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | -1.96 Mn |
| Dec 31, 2024 | -4.18 Mn |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | -6.60 Mn |
| Mar 31, 2024 | 758,000.00 |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | -6.07 Mn |
| Jun 30, 2023 | -226,000.00 |
| Mar 31, 2023 | -6.63 Mn |
| Dec 31, 2022 | -7.22 Mn |
| Sep 30, 2022 | -6.09 Mn |
| Jun 30, 2022 | 4.77 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | -5.72 Mn |
| Sep 30, 2021 | 16.16 Mn |
| Jun 30, 2021 | 10.91 Mn |